Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor 

Authors: Sophie Liabeuf, Vesna Pešić, Goce Spasovski, Romaldas Maciulaitis, Mickaël Bobot, Ana Farinha, Carsten A Wagner, Robert J Unwin, Giovambattista Capasso, Inga Arune Bumblyte, 

Gaye Hafez, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)

People living with chronic kidney disease (CKD) frequently suffer from mild cognitive impairment and/or other neurocognitive disorders. This review in two parts will focus on adverse drug reactions resulting in cognitive impairment as a potentially modifiable risk factor in CKD patients. 

View publication here.

Latest Updates


MC meeting

SAVE THE DATE: The next MC meeting will be held in Lithuania on 25-26 June 2024.

Read More

Brain-Kidney Interaction-The brain and kidney

Many CONNECT members took part in the symposium called “Brain-Kidney Interaction-The brain and kidney: from physiology to clinics”, which took place in Naples on 23-24 November 2023, with their speeches.

Read More

Fourth Call for Short-Term Scientific Mission

Fourth Call for Short-Term Scientific Mission (STSM) applications within the COST Action “Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT)” Deadline for submission: November 30th, 2023

Read More